GSK’s Voltaren Arthritis Pain Receives the US FDA’s Approval as an OTC Medication

Shots:

• The US FDA has approved Voltaren Arthritis Pain (diclofenac sodium topical gel, 1%) as an OTC for the temporary relief of arthritis pain in the hand, wrist, elbow, foot, ankle or knee in adults aged ≥18yrs.
•  The approval is based on a clinical study assessing Voltaren Arthritis Pain in patients with OA in hand & knee supporting the original prescription approval. The study demonstrated the onset of pain relief beginning as early as 1wk.
• Following the approval, Voltaren Arthritis Pain becomes the first and only prescription-strength, NSAID topical gel for arthritis pain to be available as OTC in the US

Click here ­to­ read full press release/ article | Ref: GSK  | Image: Voltaren